Resources

Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors

CISION PR Newswire

Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors

Luis Olmos

CTAD 2022: Where the future of AD clinical trials is headed

Luis Olmos

CTAD 2022: Where the future of AD clinical trials is headed

Unlearn

Endpoints at JPM23: AI in biopharma 2023 — there's no looking back

Unlearn

Endpoints at JPM23: AI in biopharma 2023 — there's no looking back

Stat News and Fierce

How will AI transform the future of medicine?

Stat News and Fierce

How will AI transform the future of medicine?

Charles K. Fisher

Top Secret Plan for AI in Medicine, Part 1

Charles K. Fisher

Top Secret Plan for AI in Medicine, Part 1

Business Wire

Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research

Business Wire

Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research

Clinical Trials Arena

Digital twins: easing the clinical trial conduct but regulatory oversight is needed

Clinical Trials Arena

Digital twins: easing the clinical trial conduct but regulatory oversight is needed

Business Wire

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

Business Wire

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

CB Insights

The Digital Health 150: The most promising digital health companies of 2022

CB Insights

The Digital Health 150: The most promising digital health companies of 2022

Fast Company

How ‘digital twins’ could change the way we develop new drugs

Fast Company

How ‘digital twins’ could change the way we develop new drugs

Business Wire

Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology

Business Wire

Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology

Applied Clinical Trials

Applied Clinical Trials: The Ins and Outs of Digital Twins

Applied Clinical Trials

Applied Clinical Trials: The Ins and Outs of Digital Twins

Business Insider

The 13 most promising early-stage artificial-intelligence startups of 2022, according to VCs investing in companies building technical infrastructure and developing tools

Business Insider

The 13 most promising early-stage artificial-intelligence startups of 2022, according to VCs investing in companies building technical infrastructure and developing tools

Proto

The People Who Never Were

Proto

The People Who Never Were

The Generalist

What to Watch in AI

The Generalist

What to Watch in AI

The AI Podcast with Jay Shah

Machine Learning Podcast with Jay Shah: AI for improving clinical trials & drug development, entrepreneurship & AI safety | Charles Fisher

The AI Podcast with Jay Shah

Machine Learning Podcast with Jay Shah: AI for improving clinical trials & drug development, entrepreneurship & AI safety | Charles Fisher

Stat News and Fierce

RCTs with prognostic digital twins overcome the limitations of external control arms

Stat News and Fierce

RCTs with prognostic digital twins overcome the limitations of external control arms

Stat News and Fierce

The future of Alzheimer’s disease research needs solutions that benefit trial patients

Stat News and Fierce

The future of Alzheimer’s disease research needs solutions that benefit trial patients

Matt Baxter Show

Matt Baxter Show Podcast: Episode 172: Charles Fisher - Founder & CEO at Unlearn

Matt Baxter Show

Matt Baxter Show Podcast: Episode 172: Charles Fisher - Founder & CEO at Unlearn

Inside Precision Medicine

Twinning is Winning

Inside Precision Medicine

Twinning is Winning

Business Wire

European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials

Business Wire

European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials

Unlearn

Summary of the EMA September 2022 Qualification Opinion for PROCOVA™

Unlearn

Summary of the EMA September 2022 Qualification Opinion for PROCOVA™

Unlearn

Unlearn presents at the 2022 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Unlearn

Unlearn presents at the 2022 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Alldus

AI in Action E380: Charles Fisher, CEO at UNLEARN.AI

Alldus

AI in Action E380: Charles Fisher, CEO at UNLEARN.AI

Charles K. Fisher

Why can’t we agree on how to define digital twins in healthcare?

Charles K. Fisher

Why can’t we agree on how to define digital twins in healthcare?

AVRA Talent

Talent + Tech Podcast: Clarity, honesty, and transparency in recruiting and onboarding with Sana Hafeez of Unlearn.ai

AVRA Talent

Talent + Tech Podcast: Clarity, honesty, and transparency in recruiting and onboarding with Sana Hafeez of Unlearn.ai

WebMD

Digital Twins May Change Clinical Trials Forever

WebMD

Digital Twins May Change Clinical Trials Forever

GOLD.

The emergence of digital twins

GOLD.

The emergence of digital twins

Inc.

Doing Good Work in More Ways than One

Inc.

Doing Good Work in More Ways than One

arXiv

Restricted mean survival time estimate using covariate adjusted pseudovalue regression to improve precision

arXiv

Restricted mean survival time estimate using covariate adjusted pseudovalue regression to improve precision

Jon Walsh

Evaluating Digital Twins for Alzheimer’s Disease using Data from a Completed Phase 2 Clinical Trial

Jon Walsh

Evaluating Digital Twins for Alzheimer’s Disease using Data from a Completed Phase 2 Clinical Trial

Alejandro Cremades

Dealmakers Podcast: This Entrepreneur Raised $70 Million To Help Develop Drugs More Ethically

Alejandro Cremades

Dealmakers Podcast: This Entrepreneur Raised $70 Million To Help Develop Drugs More Ethically

Unlearn

Case study: TwinRCTs™ reduce control arm sizes for rare neurodegenerative diseases

Unlearn

Case study: TwinRCTs™ reduce control arm sizes for rare neurodegenerative diseases

Unlearn

Unlearn presents at PSI 2022

Unlearn

Unlearn presents at PSI 2022

Clinical Trials Arena

Can AI-generated prognostic forecasts substitute patients in oncology trials?

Clinical Trials Arena

Can AI-generated prognostic forecasts substitute patients in oncology trials?

Charles K. Fisher

Applying Machine Learning to Increase Clinical Trial Efficiency: A Regulatory Journey

Charles K. Fisher

Applying Machine Learning to Increase Clinical Trial Efficiency: A Regulatory Journey

Business Wire

Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™

Business Wire

Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™

Clinical Trials Arena

Unlearn raises Series B funds to advance TwinRCTs usage in clinical trials

Clinical Trials Arena

Unlearn raises Series B funds to advance TwinRCTs usage in clinical trials

Business Wire

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Business Wire

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Fierce Biotech

Digital twin generator Unlearn nets $50M to bolster clinical trials with AI models

Fierce Biotech

Digital twin generator Unlearn nets $50M to bolster clinical trials with AI models

MedCityNews

AI startup Unlearn adds $50M for better, faster, smaller & cheaper clinical trials

MedCityNews

AI startup Unlearn adds $50M for better, faster, smaller & cheaper clinical trials

TechCrunch

Unlearn.AI, a startup developing a ‘digital twin’ service for clinical trials, raises $50M

TechCrunch

Unlearn.AI, a startup developing a ‘digital twin’ service for clinical trials, raises $50M

Charles K. Fisher

Success is never a straight line—reflecting on our EMA draft qualification opinion

Charles K. Fisher

Success is never a straight line—reflecting on our EMA draft qualification opinion

Unlearn

PROCOVA™ Handbook for the Target Trial Statistician

Unlearn

PROCOVA™ Handbook for the Target Trial Statistician

Unlearn

Summary of the EMA March 2022 Draft Qualification Opinion for PROCOVA™

Unlearn

Summary of the EMA March 2022 Draft Qualification Opinion for PROCOVA™

David Li-Bland

Unlearn presents at the 2023 ACTRIMS Forum

David Li-Bland

Unlearn presents at the 2023 ACTRIMS Forum

Venture Beat

Unlearn and Merck collaborate on medical twins trials

Venture Beat

Unlearn and Merck collaborate on medical twins trials

Business Wire

Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™

Business Wire

Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™

arXiv

Modeling Disease Progression in Mild Cognitive Impairment and Alzheimer's Disease with Digital Twins

arXiv